described in subparagraph (L) or (M) of subsection (a)(4) must establish a sliding scale fee schedule for providing covered outpatient drugs that are subject to an agreement under this section, directly or under a contractual arrangement pursuant to which a third party dispenses such drugs, to patients of the covered entity who are— (i) low-income individuals